January 19, 2011 – GE Healthcare and Veran announced a strategic supplier agreement this week in which GE became the exclusive distributor and reseller of Veran’s ig4 fusion imaging angiography navigation system in the United States.

The deal brings together GE’s Innova angiography imaging systems and Veran’s electromagnetic navigation to create a comprehensive interventional oncology solution under a single point of contact. The system allows 4-D registration capability with for precise targeting of cancerous lesions.

The multimodality Veran ig4 system helps clinicians deliver instruments to small targets in difficult to access regions of the human body in order to diagnose and treat disease minimally invasively. The navigation system uses electromagnetic localization and 4-D (x, y, z time) registration to display an interventional instrument, such as a biopsy needle or ablation needle, on a computer monitor with respect to anatomic imaging and treatment planning.

This system is compatible with GE’s Innova imaging systems, which acquire CT-like patient images of the target organ(s) that can be exported to the navigation system in the same imaging suite, during the interventional procedure. The resulting displayed image provides navigation information to help physicians insert biopsy needles, ablation (radio frequency (RF), cryotherapy and microwave) probes and other devices through the skin more quickly and with greater target accuracy. Also, using Innova CT images with Veran ig4 system may help to reduce the absorbed radiation dose through decreased use of fluoroscopy.

“This is exciting news for our customers who want to perform complex procedures in a timely fashion with more confidence. The combined systems can help clinicians achieve greater accuracy, perform procedures more quickly and reduce radiation dose,” said Chantal Le Chat, general manager of interventional radiology, GE Healthcare.

”Partnering with a global company such as GE Healthcare to significantly increase the access of our cutting edge 4-D registration technology is a great step forward for Veran Medical,” said Jerome R. Edwards, president and CEO, Veran Medical Technologies. “GE Healthcare’s healthymagination vision is extremely synergistic with the mission that Veran Medical has by having its focus directed in the interventional oncology market.”

For more information: www.gehealthcare.com, www.veranmedical.com

Related Content

News | Coronavirus (COVID-19)

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
News | Interventional Radiology

November 23, 2021 — A minimally invasive ablation procedure offers long-term relief for patients who experience chronic ...

Time November 23, 2021
arrow
News | Nuclear Imaging

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
News | Lung Imaging

November 19, 2021 — Lung cancer screening is recommended only for those who are at high risk for the disease — adults ...

Time November 19, 2021
arrow
News | Artificial Intelligence

November 18, 2021 — Worldwide the most common cause of cancer mortality in 2020 was lung cancer, with an estimated 1.80 ...

Time November 18, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
Subscribe Now